Drawing for ACCULYSE

USPTO serial 98205862

ACCULYSE

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MILMOE, MAUREEN H
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with ACCULYSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein GOODWIN PROCTER LLP620 EIGHTH AVENUENEW YORK, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; Medical apparatus, namely, infusion and injection devices for locally targeted drug administrationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 5, 2026EX4GSOU EXTENSION 4 GRANTED—
Jun 5, 2026EXT4SOU EXTENSION 4 FILED—
Jun 5, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 6, 2025EX3GSOU EXTENSION 3 GRANTED—
Nov 6, 2025EXT3SOU EXTENSION 3 FILED—
Nov 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 9, 2025EXT2SOU EXTENSION 2 FILED—
Jun 9, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 6, 2024EX1GSOU EXTENSION 1 GRANTED—
Dec 6, 2024EXT1SOU EXTENSION 1 FILED—
Dec 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 11, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 12, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 12, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 12, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 12, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2023DOCKASSIGNED TO EXAMINER—
Oct 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance